Follow the AMICUS THERAPEUTICS INC share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 6 January 2016 (Levée d'options). Among the most active insiders: Baird William D III. Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AMICUS THERAPEUTICS INC is a biopharmaceutical company focused on developing treatments for rare diseases, particularly lysosomal disorders. The company is listed on NASDAQ under the ticker symbol FOLD.